News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regeneron Pharmaceuticals, Inc. (REGN) Rushes to Complete $70 Million Expansion, Company Hopes to Hire Up to 170 to Meet Demand for Eylea


8/13/2013 11:09:36 PM

Check out other pharma companies hiring. (Isn't it tempting?)

Regeneron Pharmaceuticals is in the second phase of a $70 million expansion at its East Greenbush manufacturing plant, a project that can't be completed soon enough.

The company, which already has 670 employees here, can use the extra production capacity as it seeks to meet demand for its Eylea drug. The drug treats age-related macular degeneration, a leading cause of blindness in adults over 60.

Help employers find you! Check out all the jobs and post your resume.

Read at Times Union

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES